+Search query
-Structure paper
Title | Identification of Novel, Potent, and Orally Available GCN2 Inhibitors with Type I Half Binding Mode. |
---|---|
Journal, issue, pages | Acs Med. Chem. Lett., Vol. 10, Page 1498-1503, Year 2019 |
Publish date | Nov 15, 2018 (structure data deposition date) |
Authors | Fujimoto, J. / Kurasawa, O. / Takagi, T. / Liu, X. / Banno, H. / Kojima, T. / Asano, Y. / Nakamura, A. / Nambu, T. / Hata, A. ...Fujimoto, J. / Kurasawa, O. / Takagi, T. / Liu, X. / Banno, H. / Kojima, T. / Asano, Y. / Nakamura, A. / Nambu, T. / Hata, A. / Ishii, T. / Sameshima, T. / Debori, Y. / Miyamoto, M. / Klein, M.G. / Tjhen, R. / Sang, B.C. / Levin, I. / Lane, S.W. / Snell, G.P. / Li, K. / Kefala, G. / Hoffman, I.D. / Ding, S.C. / Cary, D.R. / Mizojiri, R. |
External links | Acs Med. Chem. Lett. / PubMed:31620240 |
Methods | X-ray diffraction |
Resolution | 2.4 - 3.01 Å |
Structure data | PDB-6n3l: PDB-6n3n: PDB-6n3o: |
Chemicals | ChemComp-KAV: ChemComp-HOH: ChemComp-KA4: ChemComp-KA7: |
Source |
|
Keywords | transferase/transferase inhibitor / GCN2 / Kinase / Inhibitor / Anti-tumor / transferase-transferase inhibitor complex |